Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Glycemic Index - Variability Among Individuals
Evaluation of Glycemic Index to Assess Diet Associated Chronic Disease Risk
Status: Enrolling
Updated:  4/24/2017
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Glycemic Index - Variability Among Individuals
Evaluation of Glycemic Index to Assess Diet Associated Chronic Disease Risk
Status: Enrolling
Updated: 4/24/2017
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Improving Self Management Skills of Older Adults With Diabetes
Improving the Self Management Skills of Older Adults With Diabetes
Status: Enrolling
Updated:  4/24/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Improving Self Management Skills of Older Adults With Diabetes
Improving the Self Management Skills of Older Adults With Diabetes
Status: Enrolling
Updated: 4/24/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes
The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes: A Controlled Feeding Trial in Overweight/Obese Adults With Central Adiposity
Status: Enrolling
Updated:  4/24/2017
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes
The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes: A Controlled Feeding Trial in Overweight/Obese Adults With Central Adiposity
Status: Enrolling
Updated: 4/24/2017
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies
Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies
Status: Enrolling
Updated:  4/24/2017
Bristlecone Behavioral Health, Inc.
mi
from
Maple Grove, MN
Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies
Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies
Status: Enrolling
Updated: 4/24/2017
Bristlecone Behavioral Health, Inc.
mi
from
Maple Grove, MN
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.
A Single Blind, Randomized, Placebo-controlled, Dose Escalating Study to Evaluate the Safety, Tolerability,Pharmacokinetic and Pharmacodynamic Parameters of Repeat Doses of GSK2330672 in Healthy Volunteers, Given Alone and With a Single Day of Dosing With GSK1614235
Status: Enrolling
Updated:  4/25/2017
GSK Investigational Site
mi
from
Baltimore, MD
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.
A Single Blind, Randomized, Placebo-controlled, Dose Escalating Study to Evaluate the Safety, Tolerability,Pharmacokinetic and Pharmacodynamic Parameters of Repeat Doses of GSK2330672 in Healthy Volunteers, Given Alone and With a Single Day of Dosing With GSK1614235
Status: Enrolling
Updated: 4/25/2017
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Sequencing T-cells in Type I Diabetes Mellitus
Sequencing T-cell Receptor Repertoire of Auto-Antigen Specific T-cells in Type I Diabetes Mellitus
Status: Enrolling
Updated:  4/25/2017
University of Texas Physicians at Trinity
mi
from
Austin, TX
Sequencing T-cells in Type I Diabetes Mellitus
Sequencing T-cell Receptor Repertoire of Auto-Antigen Specific T-cells in Type I Diabetes Mellitus
Status: Enrolling
Updated: 4/25/2017
University of Texas Physicians at Trinity
mi
from
Austin, TX
Click here to add this to my saved trials
Effect of Dietary Fat on Glycemic Control in Type 1 Diabetes
Use of Closed Loop Control to Examine the Effect of Changes in Dietary Fat Intake on Insulin Requirements and Glucose Control
Status: Enrolling
Updated:  4/25/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Effect of Dietary Fat on Glycemic Control in Type 1 Diabetes
Use of Closed Loop Control to Examine the Effect of Changes in Dietary Fat Intake on Insulin Requirements and Glucose Control
Status: Enrolling
Updated: 4/25/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM
Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM
Status: Enrolling
Updated:  5/1/2017
University of Virginia, Center for Diabetes Technology
mi
from
Charlottesville, VA
Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM
Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM
Status: Enrolling
Updated: 5/1/2017
University of Virginia, Center for Diabetes Technology
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Status: Enrolling
Updated:  5/2/2017
Wills Eye Glaucoma Service
mi
from
Philadelphia, PA
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Status: Enrolling
Updated: 5/2/2017
Wills Eye Glaucoma Service
mi
from
Philadelphia, PA
Click here to add this to my saved trials
NYULMC CareSmarts Pilot
NYULMC-CareSmarts Study: A Pilot Study to Determine the Feasibility, Acceptability, and Potential Efficacy of an SMS-based Mobile Intervention to Enhance Type 2 Diabetes Self-management
Status: Enrolling
Updated:  5/4/2017
New York University School of Medicine
mi
from
New York, NY
NYULMC CareSmarts Pilot
NYULMC-CareSmarts Study: A Pilot Study to Determine the Feasibility, Acceptability, and Potential Efficacy of an SMS-based Mobile Intervention to Enhance Type 2 Diabetes Self-management
Status: Enrolling
Updated: 5/4/2017
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Continue Glucose Monitoring Before Insulin Pump
Professional Continuous Glucose Monitoring Before Starting Insulin Pump Therapy
Status: Enrolling
Updated:  5/8/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Continue Glucose Monitoring Before Insulin Pump
Professional Continuous Glucose Monitoring Before Starting Insulin Pump Therapy
Status: Enrolling
Updated: 5/8/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents (PHM3)
Status: Enrolling
Updated:  5/9/2017
Stanford University
mi
from
Stanford, CA
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents (PHM3)
Status: Enrolling
Updated: 5/9/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents (PHM3)
Status: Enrolling
Updated:  5/9/2017
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents (PHM3)
Status: Enrolling
Updated: 5/9/2017
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes
Effect of Glucose Monitoring on Patient and Provider Outcomes in Non-insulin Treated Diabetes
Status: Enrolling
Updated:  5/10/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes
Effect of Glucose Monitoring on Patient and Provider Outcomes in Non-insulin Treated Diabetes
Status: Enrolling
Updated: 5/10/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study
Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy
Status: Enrolling
Updated:  5/11/2017
Retina Foundation of the Southwest
mi
from
Dallas, TX
Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study
Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy
Status: Enrolling
Updated: 5/11/2017
Retina Foundation of the Southwest
mi
from
Dallas, TX
Click here to add this to my saved trials
Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study
Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy
Status: Enrolling
Updated:  5/11/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study
Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy
Status: Enrolling
Updated: 5/11/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
CGM to Aid Transition From Inpatient to Outpatient
Continuous Glucose Monitoring in the Hospital to Aid in Care and Improve Transition of Care to Outpatient
Status: Enrolling
Updated:  5/15/2017
Methodist Medica Center of Illinois
mi
from
Peoria, IL
CGM to Aid Transition From Inpatient to Outpatient
Continuous Glucose Monitoring in the Hospital to Aid in Care and Improve Transition of Care to Outpatient
Status: Enrolling
Updated: 5/15/2017
Methodist Medica Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated:  5/16/2017
GSK Investigational Site
mi
from
Castro Valley, CA
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated: 5/16/2017
GSK Investigational Site
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated:  5/16/2017
GSK Investigational Site
mi
from
Miami, FL
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated: 5/16/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated:  5/16/2017
GSK Investigational Site
mi
from
Pinellas Park, FL
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated: 5/16/2017
GSK Investigational Site
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated:  5/16/2017
GSK Investigational Site
mi
from
Las Vegas, NV
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated: 5/16/2017
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated:  5/16/2017
GSK Investigational Site
mi
from
Providence, RI
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated: 5/16/2017
GSK Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated:  5/16/2017
GSK Investigational Site
mi
from
Dallas, TX
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated: 5/16/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated:  5/16/2017
GSK Investigational Site
mi
from
Washington, D.C.,
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer
Status: Enrolling
Updated: 5/16/2017
GSK Investigational Site
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Behavioral Family Systems Therapy (BFST) for Teens With Type 2 Diabetes
Behavioral Family Systems Therapy for Teens With Type 2 Diabetes: A Pilot
Status: Enrolling
Updated:  5/17/2017
Nemours Children's Specialty Care
mi
from
Jacksonville, FL
Behavioral Family Systems Therapy (BFST) for Teens With Type 2 Diabetes
Behavioral Family Systems Therapy for Teens With Type 2 Diabetes: A Pilot
Status: Enrolling
Updated: 5/17/2017
Nemours Children's Specialty Care
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Computerized Intervention of Parental Involvement in Diabetes Care of Their Child
Computer-Delivered Motivational Intervention to Improve Teen Diabetes Management
Status: Enrolling
Updated:  6/1/2017
Wayne State University
mi
from
Detroit, MI
Computerized Intervention of Parental Involvement in Diabetes Care of Their Child
Computer-Delivered Motivational Intervention to Improve Teen Diabetes Management
Status: Enrolling
Updated: 6/1/2017
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Intensive, Home-Based Family Therapy to Improve Illness Management in Youth With Diabetes
Adherence to IDDM Regimen in Urban Youth
Status: Enrolling
Updated:  6/1/2017
Children's Hospital of Michigan
mi
from
Detroit, MI
Study of Intensive, Home-Based Family Therapy to Improve Illness Management in Youth With Diabetes
Adherence to IDDM Regimen in Urban Youth
Status: Enrolling
Updated: 6/1/2017
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes
Comparative Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered Subcutaneously as a Bolus Via Syringe Versus Continuous Subcutaneous Insulin Infusion and Characterization of TID and BID Dosing at Steady State in High-Dose Insulin-Treated Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/6/2017
Profil Institute for Clinical Research
mi
from
Chula Vista, CA
A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes
Comparative Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered Subcutaneously as a Bolus Via Syringe Versus Continuous Subcutaneous Insulin Infusion and Characterization of TID and BID Dosing at Steady State in High-Dose Insulin-Treated Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/6/2017
Profil Institute for Clinical Research
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Drug Interaction Study of Simvastatin and Albiglutide
An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Simvastatin When Coadministered With Albiglutide in Healthy Adult Subjects
Status: Enrolling
Updated:  6/7/2017
GSK Investigational Site
mi
from
Austin, TX
A Drug Interaction Study of Simvastatin and Albiglutide
An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Simvastatin When Coadministered With Albiglutide in Healthy Adult Subjects
Status: Enrolling
Updated: 6/7/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
A 2-Part Trial: a Randomized 6-day Repeat-dose, Parallel-group Study in Subjects With T2DM to Assess the Safety and Tolerability of GSK1614235 Compared to Placebo and Sitagliptin; and a Randomized Single-dose, Food Effect Study in Healthy Volunteers to Assess Safety and Tolerability of GSK1614235
Status: Enrolling
Updated:  6/7/2017
GSK Investigational Site
mi
from
Miami, FL
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
A 2-Part Trial: a Randomized 6-day Repeat-dose, Parallel-group Study in Subjects With T2DM to Assess the Safety and Tolerability of GSK1614235 Compared to Placebo and Sitagliptin; and a Randomized Single-dose, Food Effect Study in Healthy Volunteers to Assess Safety and Tolerability of GSK1614235
Status: Enrolling
Updated: 6/7/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
A 2-Part Trial: a Randomized 6-day Repeat-dose, Parallel-group Study in Subjects With T2DM to Assess the Safety and Tolerability of GSK1614235 Compared to Placebo and Sitagliptin; and a Randomized Single-dose, Food Effect Study in Healthy Volunteers to Assess Safety and Tolerability of GSK1614235
Status: Enrolling
Updated:  6/7/2017
GSK Investigational Site
mi
from
Baton Rouge, LA
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
A 2-Part Trial: a Randomized 6-day Repeat-dose, Parallel-group Study in Subjects With T2DM to Assess the Safety and Tolerability of GSK1614235 Compared to Placebo and Sitagliptin; and a Randomized Single-dose, Food Effect Study in Healthy Volunteers to Assess Safety and Tolerability of GSK1614235
Status: Enrolling
Updated: 6/7/2017
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
A 2-Part Trial: a Randomized 6-day Repeat-dose, Parallel-group Study in Subjects With T2DM to Assess the Safety and Tolerability of GSK1614235 Compared to Placebo and Sitagliptin; and a Randomized Single-dose, Food Effect Study in Healthy Volunteers to Assess Safety and Tolerability of GSK1614235
Status: Enrolling
Updated:  6/7/2017
GSK Investigational Site
mi
from
Cincinnati, OH
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
A 2-Part Trial: a Randomized 6-day Repeat-dose, Parallel-group Study in Subjects With T2DM to Assess the Safety and Tolerability of GSK1614235 Compared to Placebo and Sitagliptin; and a Randomized Single-dose, Food Effect Study in Healthy Volunteers to Assess Safety and Tolerability of GSK1614235
Status: Enrolling
Updated: 6/7/2017
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
A 2-Part Trial: a Randomized 6-day Repeat-dose, Parallel-group Study in Subjects With T2DM to Assess the Safety and Tolerability of GSK1614235 Compared to Placebo and Sitagliptin; and a Randomized Single-dose, Food Effect Study in Healthy Volunteers to Assess Safety and Tolerability of GSK1614235
Status: Enrolling
Updated:  6/7/2017
GSK Investigational Site
mi
from
Gières,
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
A 2-Part Trial: a Randomized 6-day Repeat-dose, Parallel-group Study in Subjects With T2DM to Assess the Safety and Tolerability of GSK1614235 Compared to Placebo and Sitagliptin; and a Randomized Single-dose, Food Effect Study in Healthy Volunteers to Assess Safety and Tolerability of GSK1614235
Status: Enrolling
Updated: 6/7/2017
GSK Investigational Site
mi
from
Gières,
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Honolulu, HI
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Louisville, KY
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Columbus, OH
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Dayton, OH
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Lansdale, PA
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Lansdale, PA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Greer, SC
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
San Antonio, TX
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Troy, MI
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Cooper City, FL
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Cooper City, FL
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Rapid City, SD
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Chula Vista, CA
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Merck Sharp & Dohme (Argentina) Inc.
mi
from
Buenos Aires,
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Merck Sharp & Dohme (Argentina) Inc.
mi
from
Buenos Aires,
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Fargo, ND
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/8/2017
Clinical Research Facility
mi
from
Lyndhurst, OH
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/8/2017
Clinical Research Facility
mi
from
Lyndhurst, OH
Click here to add this to my saved trials
Inducing Remission in Type 1 Diabetes With Alefacept
Inducing Remission in New Onset Type 1 Diabetes Mellitus With Alefacept (Amevive®)
Status: Enrolling
Updated:  6/12/2017
Emory University
mi
from
Atlanta, GA
Inducing Remission in Type 1 Diabetes With Alefacept
Inducing Remission in New Onset Type 1 Diabetes Mellitus With Alefacept (Amevive®)
Status: Enrolling
Updated: 6/12/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials